Fibrocell Sciences, Inc. (ILEIQ) - Product Pipeline Analysis

Document Sample
Fibrocell Sciences, Inc. (ILEIQ) - Product Pipeline Analysis Powered By Docstoc
					                              Fibrocell Sciences, Inc. (ILEIQ) - Product Pipeline Analysis

     Reference Code: GDMEPH214199PD                                                                                             Publication Date: NOV 2010



     Company Snapshot                                                         Company Overview
     Key Information
                                                                              Fibrocell Sciences, Inc. (Fibrocell Sciences), formerly Isolagen, Inc., is a
      Fibrocell Sciences, Inc., Key Facts                                     biotechnology company engaged in the development of regenerative cell
                                                                              therapy for aesthetic, medical and scientific applications. The Fibrocell
      Web Address                            www.isolagen.com
                                                                              therapy is an investigational autologous cell therapy in which natural
      Turnover (in USD Million)              0.90                             fibroblasts are extracted, multiplied and re-injected as personalized
                                                                              therapy. The company prepares the Fibrocell therapy through a
      Number of Employees                    11                               streamlined process that begins with removing a small sample of cells
      Industry                               Pharmaceuticals and Healthcare   behind a patient’s ear. It focuses on the treatment of nasolabial fold
      Source:Primary / Secondary Research                                     wrinkles in patients through its azficel-T.
      GlobalData




     Fibrocell Sciences, Inc. Pipeline Products

     Fibrocell Sciences, Inc. Key Pipeline Products by                        Fibrocell Sciences, Inc. Key Pipeline Products by Therapy Area
     Equipment Type
     Equipment Type                             No of Products                Therapy Area                                               No of Products
     Aesthetic Devices                                      4                 Acne scars                                                             1
                                                                              Restrictive burn scars                                                    1
                                                                              Wrinkles                                                                  1
      Source: Primary / Secondary Research                                    Source: Primary / Secondary Research
      GlobalData                                                              GlobalData




      Fibrocell Sciences, Inc. Key Pipeline Products by Development Stage

     Developmental Stage                                                                                                                 No of Products
     Clinicals                                                                                                                                       4
     Pre-Clinicals                                                                                                   -
     Early development                                                                                               -
      Source: Primary / Secondary Research
      GlobalData
      Note : (-) indicates 'Not Available'



      Fibrocell Sciences, Inc. Key Pipeline Products by Trial Phase

     Trial Phase                                                                                                                         No of Products
     Phase IV                                                                                                        -
     Phase III                                                                                                                                          2
     Phase II                                                                                                                                           3
     Phase I                                                                                                         -
      Source: Primary / Secondary Research
      GlobalData
      Note : (-) indicates 'Not Available'




Fibrocell Sciences, Inc. (ILEIQ) - Product Pipeline Analysis                                                                    Reference Code: GDMEPH214199PD

Source : www.globalcompanyintelligence.com                                                                                                                   Page 1
     Table of Contents
     Table of Contents................................................................................................................................................................................................................................................................... 2
     List of Tables .......................................................................................................................................................................................................................................................................... 3
     List of Figures......................................................................................................................................................................................................................................................................... 4
     Key Facts ............................................................................................................................................................................................................................................................................... 5
     Fibrocell Sciences, Inc. - Major Products and Services ......................................................................................................................................................................................................... 6
           Fibrocell Sciences, Inc. Pipeline Products by Equipment Type....................................................................................................................................................................................... 7
           Fibrocell Sciences, Inc. Pipeline Products by Development Stage ................................................................................................................................................................................. 9
           Fibrocell Sciences, Inc. Pipeline Products by Therapy Area ......................................................................................................................................................................................... 11
           Fibrocell Sciences, Inc. Pipeline Products by Trial Phase............................................................................................................................................................................................. 13
           Isolagen Therapy ........................................................................................................................................................................................................................................................... 15
                 Product Status......................................................................................................................................................................................................................................................... 15
                 Product Description ................................................................................................................................................................................................................................................. 15
                 Product Milestone ................................................................................................................................................................................................................................................... 15
                 Isolagen Therapy Clinical Trial................................................................................................................................................................................................................................ 16
                 Product Patent Details ............................................................................................................................................................................................................................................ 21
           Isolagen Therapy For Acne Scars ................................................................................................................................................................................................................................. 23
                 Product Status......................................................................................................................................................................................................................................................... 23
                 Product Description ................................................................................................................................................................................................................................................. 23
                 Product Milestone ................................................................................................................................................................................................................................................... 23
                 Isolagen Therapy For Acne Scars Clinical Trial ...................................................................................................................................................................................................... 24
                 Product Patent Details ............................................................................................................................................................................................................................................ 25
           Isolagen Therapy For Full Face..................................................................................................................................................................................................................................... 26
                 Product Status......................................................................................................................................................................................................................................................... 26
                 Product Description ................................................................................................................................................................................................................................................. 26
                 Isolagen Therapy For Full Face Clinical Trial.......................................................................................................................................................................................................... 26
                 Product Patent Details ............................................................................................................................................................................................................................................ 27
           Isolagen Therapy For Restrictive Burn Scars ................................................................................................................................................................................................................ 28
                 Product Status......................................................................................................................................................................................................................................................... 28
                 Product Description ................................................................................................................................................................................................................................................. 28
                 Isolagen Therapy For Restrictive Burn Scars Clinical Trial..................................................................................................................................................................................... 29
                 Product Patent Details ............................................................................................................................................................................................................................................ 31
     Fibrocell Sciences, Inc. - Key Competitors .......................................................................................................................................................................................................................... 33
     Fibrocell Sciences, Inc. - Key Employees ............................................................................................................................................................................................................................ 34
     Fibrocell Sciences, Inc. - Locations And Subsidiaries.......................................................................................................................................................................................................... 35
           Head Office.................................................................................................................................................................................................................................................................... 35
           Other Locations & Subsidiaries ..................................................................................................................................................................................................................................... 35
     Recent Developments.......................................................................................................................................................................................................................................................... 36
                 Jul 20, 2010: Fibrocell Appoints George Korkos To Board ..................................................................................................................................................................................... 36
                 May 13, 2010: Fibrocell Science Initiates Histology Study Of azficel-T .................................................................................................................................................................. 36
                 Feb 02, 2010: Fibrocell Appoints David Pernock As CEO ...................................................................................................................................................................................... 36
                 Jun 16, 2009: sd...................................................................................................................................................................................................................................................... 36
                 Mar 20, 2009: Isolagen Receives Delisting Notice From AMEX ............................................................................................................................................................................. 36
     Appendix .............................................................................................................................................................................................................................................................................. 38
           Methodology .................................................................................................................................................................................................................................................................. 38
           About GlobalData .......................................................................................................................................................................................................................................................... 38
           Contact Us ..................................................................................................................................................................................................................................................................... 38
           Disclaimer ...................................................................................................................................................................................................................................................................... 38




Fibrocell Sciences, Inc. (ILEIQ) - Product Pipeline Analysis                                                                                                                                                                                  Reference Code: GDMEPH214199PD

Source : www.globalcompanyintelligence.com                                                                                                                                                                                                                                                     Page 2
     List of Tables
     Fibrocell Sciences, Inc., Key Facts ................................................................................................................................................................................................
				
DOCUMENT INFO
Description: Fibrocell Sciences, Inc. (ILEIQ) - Product Pipeline Analysis Summary This report is a source for data, analysis and actionable intelligence on the Fibrocell Sciences, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibili
BUY THIS DOCUMENT NOW PRICE: $750 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.